← Back to Search

Nonsteroidal Anti-inflammatory Drug

Indomethacin vs Ibuprofen for Preterm Labor (TOCO Trial)

N/A
Waitlist Available
Led By Pamela Simmons, DO
Research Sponsored by Woman's
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
≥ 18 years old
Exam or ultrasound indicated cerclage placement
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from cerclage placement to delivery
Awards & highlights

TOCO Trial Summary

This trial is investigating whether the drug indomethacin, which is traditionally used to treat cervical insufficiency, is more effective than the drug ibuprofen in prolonging pregnancy.

Who is the study for?
This trial is for pregnant women between 16 and nearly 24 weeks along, with a single baby and intact membranes needing emergency cerclage to prevent early labor. They must be over 18, planning to deliver at Woman's Hospital, and not have used ibuprofen or indomethacin recently.Check my eligibility
What is being tested?
The study compares two drugs—ibuprofen (2400mg) and indomethacin (150mg)—to see which one better prolongs pregnancy after an emergency stitch (cerclage) is placed in the cervix due to premature dilation.See study design
What are the potential side effects?
Possible side effects of both medications include digestive issues like stomach pain or ulcers, kidney problems, increased blood pressure, and potential risks to fetal health.

TOCO Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
My exam or ultrasound showed I need a cerclage.

TOCO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at delivery
This trial's timeline: 3 weeks for screening, Varies for treatment, and at delivery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Gestational latency
Secondary outcome measures
Preterm birth

TOCO Trial Design

2Treatment groups
Active Control
Group I: IbuprofenActive Control1 Intervention
Ibuprofen 600 mg q6 hours for 24 hours- total dose of 2400mg- after emergent cerclage placement
Group II: IndomethacinActive Control1 Intervention
Indomethacin 50 mg q8 hours for 24 hours- total dose of 150mg- after emergent cerclage placement

Find a Location

Who is running the clinical trial?

Woman'sLead Sponsor
17 Previous Clinical Trials
1,354 Total Patients Enrolled
Pamela Simmons, DOPrincipal InvestigatorWoman's Hospital, Louisiana

Media Library

Ibuprofen (Nonsteroidal Anti-inflammatory Drug) Clinical Trial Eligibility Overview. Trial Name: NCT04726085 — N/A
Preterm Labor Research Study Groups: Ibuprofen, Indomethacin
Preterm Labor Clinical Trial 2023: Ibuprofen Highlights & Side Effects. Trial Name: NCT04726085 — N/A
Ibuprofen (Nonsteroidal Anti-inflammatory Drug) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04726085 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Have there been any additional investigations regarding the efficacy of Ibuprofen?

"At this moment, 56 Ibuprofen clinical trials have been launched. Of those, 14 are in the third phase of development. Sacramento, California is a hub for these studies; however there are 151 sites across the country conducting research on Ibuprofen."

Answered by AI

What maladies is Ibuprofen generally administered to address?

"Ibuprofen is commonly used as a supplemental treatment for those that have not responded to more traditional remedies. It can be employed to alleviate symptoms like catarrh and muscle spasms, as well as degenerative polyarthritis."

Answered by AI

What is the target enrollment for this trial?

"Affirmative. The clinical trial's details, which were initially posted on February 1st 2021, are available to view on the website clinicaltrials.gov and confirm that recruitment is currently ongoing. This study requires a total of 100 volunteers who will be based at one site."

Answered by AI

Are any participants being enlisted in this trial at the moment?

"Yes, clinicaltrials.gov indicates that this medical research trial is actively recruiting volunteers with the original posting date of February 1st 2021 and a recent update on May 3rd 2022."

Answered by AI
~17 spots leftby Jan 2025